Ortin Global Q3 Results
- BSE: 539287
- NSE: ORTINGLOBE
- ISIN: INE749B01020
- Sector: Biotechnology & Drugs
BSE
12.79
0.59 (4.84%)
0.59 (4.84%)Volume110.00
Updated: Fri 6 Feb, 2026 | 14:30:51
NSE
12.060.03 (0.25%)
0.03 (0.25%)Volume2.77 K
Updated: Fri 6 Feb, 2026 | 14:30:42
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Ortin Global Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.15 | 0.51 | -70.63% | 2.80 | -94.67% |
| Depreciation/ Amortization | 0.00 | 0.00 | -56.25% | 0.06 | -96.66% |
| Operating Income | -0.12 | -0.45 | -74.47% | -2.67 | -95.65% |
| Net Income | -0.11 | -0.47 | -77.37% | -2.79 | -96.17% |
| Other Operating Expenses Total | 0.09 | 0.40 | -77.13% | 0.22 | -57.96% |
| Net Income Before Taxes | -0.10 | -0.47 | -78.59% | -2.81 | -96.39% |
| Total Revenue | 0.03 | 0.05 | -38.87% | 0.14 | -75.39% |
| Selling/ General/ Admin Expenses Total | 0.04 | 0.03 | 23.63% | 0.06 | -30.69% |
| Diluted Normalized EPS | -0.15 | -0.58 | -74.97% | -3.43 | -95.77% |